Market cap
₹74 Cr
Revenue (TTM)
₹25 Cr
P/E Ratio
14.4
P/B Ratio
2.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 13.09 | 216.40 | -- |
| EBIT | -- | -- | 0.58 | 220.83 | -- |
| Net Profit | -- | -- | 4.45 | 174.20 | -- |
| EPS | -- | -- | 4.45 | 174.20 | -- |
| Book Value | -- | -- | 102.97 | 203.13 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 24.01 | -- | 27.05 | 30.41 | 14.56 |
| Net Margin
| 18.39 | -- | 20.74 | 22.55 | 11.89 |
| Return on equity
| 87.46 | -- | 67.97 | 194.42 | 0.00 |
| Return on Capital
| 181.24 | -- | 91.42 | 246.23 | 206.07 |
| Return on Assets
| 60.84 | -- | 46.95 | 89.78 | 45.78 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.01 | 5.62 |
Profitability
ROCE
91.42
Higher than Peers by 71.07
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
91.42
|
246.23
|
206.07
|
-1,322.42
|
--
|
|
Peer Median
|
20.34
|
38.87
|
1.24
|
20.48
|
--
|
ROE
67.97
Higher than Peers by 57.03
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
67.97
|
194.42
|
--
|
--
|
--
|
|
Peer Median
|
10.95
|
28.01
|
0.76
|
14.31
|
--
|
ROA
46.95
Higher than Peers by 32.01
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
46.95
|
89.78
|
45.78
|
-385.64
|
--
|
|
Peer Median
|
14.95
|
17.09
|
18.27
|
18.28
|
--
|
EBIT Margin
27.05
Higher than Peers by 0.82
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
27.05
|
30.41
|
14.56
|
-27.62
|
--
|
|
Peer Median
|
26.23
|
20.47
|
16.56
|
22.52
|
--
|
Net Margin
20.74
Higher than Peers by 11.06
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
20.74
|
22.55
|
11.89
|
-35.75
|
--
|
|
Peer Median
|
9.68
|
9.46
|
15.20
|
13.62
|
--
|
Cash Profit Margin
21.40
Higher than Peers by 21.40
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
21.40
|
22.85
|
11.91
|
-35.70
|
--
|
|
Peer Median
|
0.00
|
0.00
|
--
|
0.00
|
--
|
Revenue Growth
13.09
Higher than Peers by 2.48
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
13.09
|
532.24
|
343.01
|
--
|
--
|
|
Peer Median
|
10.61
|
9.52
|
-2.17
|
7.39
|
--
|
EBIT Growth
0.58
Lower than Peers by 71.12
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
0.58
|
1,220.34
|
333.61
|
--
|
--
|
|
Peer Median
|
71.70
|
9.23
|
-40.04
|
32.22
|
--
|
Net Profit Growth
4.45
Lower than Peers by 98.31
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
4.45
|
1,109.75
|
247.32
|
--
|
--
|
|
Peer Median
|
102.76
|
14.14
|
-23.96
|
127.64
|
--
|
EPS Growth
4.45
Lower than Peers by 102.10
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
4.45
|
1,109.71
|
247.33
|
--
|
--
|
|
Peer Median
|
106.54
|
61.80
|
-23.96
|
153.31
|
--
|
Book Value Growth
102.97
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
102.97
|
6,968.24
|
118.02
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
--
|
0.01
|
5.62
|
-1.04
|
--
|
|
Peer Median
|
0.01
|
0.02
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
--
|
0.01
|
5.62
|
-1.04
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.61
Higher than Peers by 0.31
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
2.61
|
0.54
|
1.03
|
0.17
|
--
|
|
Peer Median
|
2.30
|
1.69
|
2.26
|
2.04
|
--
|
Quick Ratio
2.04
Higher than Peers by 0.16
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
2.04
|
0.44
|
0.65
|
0.17
|
--
|
|
Peer Median
|
1.88
|
1.56
|
1.37
|
1.09
|
--
|
Interest Coverage
172.13
Higher than Peers by 157.34
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
172.13
|
69.02
|
203.56
|
-30.31
|
--
|
|
Peer Median
|
14.79
|
33.08
|
15.20
|
15.20
|
--
|
Operating Efficiency
Debtors to sales
9.91
Lower than Peers by 7.97
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
9.91
|
0.75
|
--
|
--
|
--
|
|
Peer Median
|
17.88
|
18.78
|
15.72
|
12.35
|
--
|
Asset Turnover
2.23
Higher than Peers by 0.56
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
2.23
|
3.95
|
3.85
|
10.79
|
--
|
|
Peer Median
|
1.68
|
1.57
|
1.39
|
1.09
|
--
|
Receivable days
19.30
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
19.30
|
2.73
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
13.89
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
13.89
|
8.83
|
66.38
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
56.22
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
56.22
|
44.99
|
74.51
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-23.03
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
-23.03
|
-33.43
|
-8.12
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
70.48
|
72.83
|
65.48
|
44.27
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.64
|
6.39
|
2.00
|
2.29
|
--
|
EV/EBITDA
0.60
Lower than Peers by 43.71
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
0.60
|
-0.01
|
-1.12
|
-1.91
|
--
|
|
Peer Median
|
44.31
|
43.33
|
6.48
|
6.92
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Ravelcare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
643
|
613
|
140
|
145
|
--
|